Celularity (CELU) Equity Average (2020 - 2025)
Celularity (CELU) has disclosed Equity Average for 6 consecutive years, with -$22.8 million as the latest value for Q3 2025.
- On a quarterly basis, Equity Average fell 201.11% to -$22.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$22.8 million, a 201.11% decrease, with the full-year FY2024 number at $24.9 million, down 79.24% from a year prior.
- Equity Average was -$22.8 million for Q3 2025 at Celularity, down from -$15.5 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $181.6 million in Q4 2022 to a low of -$630.1 million in Q2 2021.
- A 5-year average of -$17.8 million and a median of $35.6 million in 2023 define the central range for Equity Average.
- Peak YoY movement for Equity Average: surged 156.95% in 2022, then tumbled 201.11% in 2025.
- Celularity's Equity Average stood at $97.8 million in 2021, then soared by 85.62% to $181.6 million in 2022, then tumbled by 80.39% to $35.6 million in 2023, then crashed by 63.32% to $13.1 million in 2024, then plummeted by 274.56% to -$22.8 million in 2025.
- Per Business Quant, the three most recent readings for CELU's Equity Average are -$22.8 million (Q3 2025), -$15.5 million (Q2 2025), and $1.7 million (Q1 2025).